Literature DB >> 11241835

Restricting Bmp-4 mediated apoptosis in hindbrain neural crest.

A Smith1, A Graham.   

Abstract

The segregation of the rhombencephalic neural crest into three streams, destined for particular pharyngeal arches, is a prominent feature of the developing vertebrate head and is likely necessary for normal morphogenesis. At least in part, the segregation of the crest into these streams involves the focal depletion of neural crest from rhombomeres 3 and 5 through large-scale apoptosis, mediated by the induction of Bmp-4 expression in the crest primordia of these two rhombomeres. Previously we found that in contrast to rhombomeres 3 and 5, the intervening segment rhombomere 4 was not susceptible to Bmp-4-sponsored neural crest cell death. To analyse the reason for this difference, we have isolated clones for the necessary components of the Bmp-4 signal transduction apparatus. We find that the hindbrain neural crest generally is primed to respond to Bmp-4 and that in vitro, besides rhombomere 3 and 5, rhombomeres 2 and 6 are also sensitive to Bmp-4-sponsored death. As before, however, we find that rhombomere 4 will not respond to this factor. Our analysis of the Bmp-4 antagonists has uncovered a reason for this. Rhombomere 4 expresses elevated levels of the antagonist Noggin at its dorsal midline just as crest production from this segment commences and, as development proceeds, in the crest that migrates away from there. At these later stages, expression also becomes apparent in the migratory post-otic crest as it flows by the otic vesicle. An interesting feature of these domains of Noggin expression is that they lie between territories of Bmp-4 expression, suggesting that Noggin is acting to protect from Bmp-4-mediated cell death. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241835     DOI: 10.1002/1097-0177(20010301)220:3<276::AID-DVDY1110>3.0.CO;2-5

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  8 in total

Review 1.  The development and evolution of the pharyngeal arches.

Authors:  A Graham
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

Review 2.  Regional differences in neural crest morphogenesis.

Authors:  Bryan R Kuo; Carol A Erickson
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

3.  NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade.

Authors:  Stephen E Kendall; Chiara Battelli; Sarah Irwin; Jane G Mitchell; Carlotta A Glackin; Joseph M Verdi
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells.

Authors:  Maike Haubold; Andreas Weise; Harald Stephan; Nicole Dünker
Journal:  Int J Biol Sci       Date:  2010-11-24       Impact factor: 6.580

Review 5.  Reprogramming multipotent tumor cells with the embryonic neural crest microenvironment.

Authors:  Jennifer C Kasemeier-Kulesa; Jessica M Teddy; Lynne-Marie Postovit; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix; Paul M Kulesa
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

6.  Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome.

Authors:  Tom Van de Putte; Mitsuji Maruhashi; Annick Francis; Luc Nelles; Hisato Kondoh; Danny Huylebroeck; Yujiro Higashi
Journal:  Am J Hum Genet       Date:  2003-01-09       Impact factor: 11.025

7.  Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons.

Authors:  H N Beck; K Drahushuk; D B Jacoby; D Higgins; P J Lein
Journal:  BMC Neurosci       Date:  2001-09-11       Impact factor: 3.288

8.  A role for NRAGE in NF-kappaB activation through the non-canonical BMP pathway.

Authors:  Nicholas Matluk; Jennifer A Rochira; Aldona Karaczyn; Tamara Adams; Joseph M Verdi
Journal:  BMC Biol       Date:  2010-01-25       Impact factor: 7.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.